ResMed Inc. (CHESS)’s “Hold” Rating Reaffirmed at Deutsche Bank (RMD)
ResMed Inc. (CHESS) (ASX:RMD)‘s stock had its “hold” rating reaffirmed by equities researchers at Deutsche Bank in a research report issued on Thursday, American Banking News reports.
ResMed Inc. (ASX:RMD) traded down 1.63% on Thursday, hitting A$4.830. 4,155,272 shares of the company’s stock traded hands. ResMed Inc. has a 52 week low of A$4.120 and a 52 week high of A$5.940. The stock’s 50-day moving average is A$5.25 and its 200-day moving average is A$5.36. The company has a market cap of A$6.842 billion and a price-to-earnings ratio of 22.02.
ResMed Inc, (ASX:RMD) is a holding company for the ResMed Group.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.